Vistagen Therapeutics, Inc. (VTGN) Reports Material Event to SEC
Filing Details Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed a Form 8-K with the Securities and Exchange Commission on July 31, 2026, disclosing a material event. Market Context…
Read more
